Literature DB >> 23179333

Inflammatory cytokine measurement quickly discriminates gram-negative from gram-positive bacteremia in pediatric hematology/oncology patients with septic shock.

Xiao-Jun Xu1, Yong-Min Tang, Chan Liao, Hua Song, Shi-Long Yang, Wei-Qun Xu, Shu-Wen Shi, Ning Zhao.   

Abstract

PURPOSE: We performed a prospective study to evaluate the ability of inflammatory cytokines in discriminating gram-negative from gram-positive bacteremia in septic shock.
METHODS: During the study period, the serum inflammatory cytokine levels were measured at the onset of septic shock by flow cytometry in pediatric hematology/oncology patients with septic shock.
RESULTS: One hundred episodes of septic shock were enrolled. Of 97 episodes of monomicrobial infection, 73.2 % were caused by gram-negative bacteremia and 26.8 % by gram-positive bacteremia. Interleukin (IL)-6, IL-10, and tumor necrosis factor (TNF)-α were closely related to the pediatric index of mortality 2 (PIM2) score and mortality. However, although the PIM2 score and mortality were comparable, the IL-6, IL-10, and TNF-α levels were significantly higher in patients with gram-negative bacteremia (GNB) than those with gram-positive bacteremia (median levels, pg/mL: IL-6: 784.1 vs. 254.4, P = 0.001; IL-10: 192.2 vs. 19.7, P < 0.001; TNF-α: 4.2 vs. 2.0, P < 0.001). Of the three cytokines, IL-10 was the most useful biomarker for GNB prediction in the derivation cohort and a cutoff value of 50 pg/mL showed a sensitivity of 70.8 % and a specificity of 80.0 %, with a positive predictive value of 89.5 %. When this cutoff value was applied to the validation cohort, the sensitivity, specificity, and positive predictive value were 80.9, 75.0, and 90.5 %, respectively.
CONCLUSIONS: Flow cytometry-based inflammatory cytokine measurement is a helpful adjuvant approach for early and quick discrimination of gram-negative from gram-positive bacteremia in pediatric hematology/oncology patients with septic shock which might be useful for evaluating the severity of shock and the selection and/or timely withdrawal or switch of antibiotics.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23179333     DOI: 10.1007/s00134-012-2752-4

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  30 in total

1.  Quantitative validation and comparison of multiplex cytokine kits.

Authors:  Joanna L Richens; Richard A Urbanowicz; Rebecca Metcalf; Jonathan Corne; Paul O'Shea; Lucy Fairclough
Journal:  J Biomol Screen       Date:  2010-02-22

2.  Prediction of gram-negative bacteremia in patients with cancer and febrile neutropenia by means of interleukin-8 levels in serum: targeting empirical monotherapy versus combination therapy.

Authors:  W V Kern; M Heiss; G Steinbach
Journal:  Clin Infect Dis       Date:  2001-02-23       Impact factor: 9.079

3.  Incidence and risk factors for mortality in paediatric severe sepsis: results from the national paediatric intensive care registry in Japan.

Authors:  Nobuaki Shime; Tatsuya Kawasaki; Osamu Saito; Yoko Akamine; Yuichiro Toda; Muneyuki Takeuchi; Hiroko Sugimura; Yoshio Sakurai; Masatoshi Iijima; Ikuya Ueta; Naoki Shimizu; Satoshi Nakagawa
Journal:  Intensive Care Med       Date:  2012-04-18       Impact factor: 17.440

4.  Serum levels of IL-1 beta, sIL-2R, IL-6, IL-8, and TNF-alpha in febrile children with cancer and neutropenia.

Authors:  M Soker; L Colpan; A Ece; C Devecioğlu; K Haspolat
Journal:  Med Oncol       Date:  2001       Impact factor: 3.064

5.  Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia.

Authors:  Cristina Prat; Juan Manuel Sancho; Josep Dominguez; Blanca Xicoy; Montse Gimenez; Christelle Ferra; Silvia Blanco; Alicia Lacoma; Josep Maria Ribera; Vicenc Ausina
Journal:  Leuk Lymphoma       Date:  2008-09

6.  Early diagnostic and prognostic significance of a specific Th1/Th2 cytokine pattern in children with haemophagocytic syndrome.

Authors:  Yongmin Tang; Xiaojun Xu; Hua Song; Shilong Yang; Shuwen Shi; Jian Wei; Binhua Pan; Fenying Zhao; Chan Liao; Chunfang Luo
Journal:  Br J Haematol       Date:  2008-07-31       Impact factor: 6.998

7.  The determinants of hospital mortality among patients with septic shock receiving appropriate initial antibiotic treatment*.

Authors:  Andrew Labelle; Paul Juang; Richard Reichley; Scott Micek; Justin Hoffmann; Alex Hoban; Nicholas Hampton; Marin Kollef
Journal:  Crit Care Med       Date:  2012-07       Impact factor: 7.598

8.  Impact of organ dysfunction on mortality in ICU patients with hematologic malignancies.

Authors:  Dominique M Vandijck; Pieter O Depuydt; Fritz C Offner; Joke Nollet; Renaat A Peleman; Eva Steel; Lucien A Noens; Johan M Decruyenaere; Dominique D Benoit
Journal:  Intensive Care Med       Date:  2010-05-18       Impact factor: 17.440

9.  Differences in lipopolysaccharide- and lipoteichoic acid-induced cytokine/chemokine expression.

Authors:  Simon J Finney; Susannah K Leaver; Timothy W Evans; Anne Burke-Gaffney
Journal:  Intensive Care Med       Date:  2011-12-20       Impact factor: 17.440

Review 10.  Bench-to-bedside review: sepsis, severe sepsis and septic shock - does the nature of the infecting organism matter?

Authors:  Hongmei Gao; Timothy W Evans; Simon J Finney
Journal:  Crit Care       Date:  2008-05-06       Impact factor: 9.097

View more
  23 in total

1.  Host derived biomarkers of inflammation, apoptosis, and endothelial activation are associated with clinical outcomes in patients with bacteremia and sepsis regardless of microbial etiology.

Authors:  William O Hahn; Carmen Mikacenic; Brenda L Price; Susanna Harju-Baker; Ronit Katz; Jonathan Himmelfarb; Mark M Wurfel; W Conrad Liles
Journal:  Virulence       Date:  2016-01-28       Impact factor: 5.882

2.  Prognostic markers for pediatric septic shock: which ones, when, and how?

Authors:  Corsino Rey; James D Fortenberry
Journal:  Intensive Care Med       Date:  2013-07-31       Impact factor: 17.440

3.  Longitudinal profiling of plasma cytokines in melioidosis and their association with mortality: a prospective cohort study.

Authors:  T Kaewarpai; P Ekchariyawat; R Phunpang; S W Wright; A Dulsuk; B Moonmueangsan; C Morakot; E Thiansukhon; N P J Day; G Lertmemongkolchai; T E West; N Chantratita
Journal:  Clin Microbiol Infect       Date:  2019-11-07       Impact factor: 8.067

Review 4.  CAR T Cell Therapy for Hematological Malignancies.

Authors:  Xin Yang; Gao-Xiang Wang; Jian-Feng Zhou
Journal:  Curr Med Sci       Date:  2019-12-16

5.  De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study.

Authors:  Djamel Mokart; Géraldine Slehofer; Jérôme Lambert; Antoine Sannini; Laurent Chow-Chine; Jean-Paul Brun; Pierre Berger; Ségolène Duran; Marion Faucher; Jean-Louis Blache; Colombe Saillard; Norbert Vey; Marc Leone
Journal:  Intensive Care Med       Date:  2014-01       Impact factor: 17.440

6.  CRP/albumin ratio: A promising marker of gram-negative bacteremia in late-onset neonatal sepsis.

Authors:  Hatice Güneş; Sadık Yurttutan; Mustafa Çobanuşağı; Adem Doğaner
Journal:  Turk Arch Pediatr       Date:  2021-01-01

7.  Cytokine profile in severe Gram-positive and Gram-negative abdominal sepsis.

Authors:  Maja Surbatovic; Nada Popovic; Danilo Vojvodic; Ivan Milosevic; Gordana Acimovic; Milan Stojicic; Milic Veljovic; Jasna Jevdjic; Dragan Djordjevic; Sonja Radakovic
Journal:  Sci Rep       Date:  2015-06-16       Impact factor: 4.379

Review 8.  How to treat severe infections in critically ill neutropenic patients?

Authors:  Lara Zafrani; Elie Azoulay
Journal:  BMC Infect Dis       Date:  2014-11-28       Impact factor: 3.090

9.  The clinical application value of cytokines in treating infectious diseases.

Authors:  Qing Ye; Wen-Xia Shao; Xiao-Jun Xu; Ying-zhi Yang
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

10.  Comparison of Th1/Th2 cytokine profiles between primary and secondary haemophagocytic lymphohistiocytosis.

Authors:  Yuanyuan Chen; Zhujun Wang; Zebin Luo; Ning Zhao; Shilong Yang; Yongmin Tang
Journal:  Ital J Pediatr       Date:  2016-05-21       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.